Norman v. NYU Langone Health System

CourtDistrict Court, S.D. New York
DecidedSeptember 30, 2020
Docket1:19-cv-00067
StatusUnknown

This text of Norman v. NYU Langone Health System (Norman v. NYU Langone Health System) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Norman v. NYU Langone Health System, (S.D.N.Y. 2020).

Opinion

USDC SDNY UNITED STATES DISTRICT COURT DOCUMENT SOUTHERN DISTRICT OF NEW YORK ELECTRONICALLY FILED JASMINE NORMAN, DOC # DATE FILED: _ 9/30/2020 Plaintiff, -against- 19 Civ. 67 (AT) NYU LANGONE HEALTH SYSTEM, ORDER Defendant. ANALISA TORRES, District Judge: Plaintiff, Jasmine Norman, brings this action against her employer, Defendant, NYU Langone Health System, alleging that Defendant violated her rights under the Americans with Disabilities Act (the “ADA”), 42 U.S.C. § 12101, et seq.; the New York State Human Rights Law (the “NYSHRL”), N.Y. Exec. L. § 296, ef seg.; and the New York City Human Rights Law (the “NYCHRL”), N-.Y.C. Admin. Code § 8-101, et seg. Compl. § 1, ECF No. 1. She claims to have a disability—an allergy to the flu vaccine—and alleges failure to accommodate her disability, disability discrimination, and retaliation. Defendant moves for summary judgment. ECF No. 46. For the reasons stated below, Defendant’s motion is GRANTED as to Plaintiff's claims under the ADA. Plaintiff's state and local law claims are DISMISSED without prejudice. BACKGROUND The facts discussed in this opinion are undisputed except where otherwise noted. The Court has drawn all reasonable inferences in favor of Plaintiff, as the nonmovant. See Costello v. City of Burlington, 632 F.3d 41, 45 (2d Cir. 2011).'

1 The following facts are drawn from the parties’ pleadings and submissions, including the complaint, Defendant’s Rule 56.1 statement of undisputed facts and Plaintiff's response, Plaintiff's statement of additional material facts and Defendant’s response, and the parties’ declarations. Facts in dispute are so noted. Citations to a paragraph in Defendant’s Rule 56.1 statement also include Plaintiff's response, and citations to a paragraph in Plaintiff's counterstatement include Defendant’s response.

Plaintiff, Jasmine Norman, has been employed by Defendant, NYU Langone Health System, since April 25, 2011 when she was hired as a Clinical Database Specialist. 56.1 Stmt. ¶ 1, ECF No. 63-1. Over the years, she rose through the ranks, attaining in 2019 the title of Senior Project Manager, Hospital Operations. Id. ¶ 4. Her work has not involved direct contact with patients, nor has she worked in areas where patients are typically present. Id. ¶ 6.

In 2013, Defendant implemented an Immunity Requirements Policy (the “IRP”), requiring that employees in areas where patients may be present either receive an annual flu vaccine or obtain an approved exemption based on a medical, religious, or personal reason. Id. ¶ 18. Until 2016, Defendant granted all exemption requests for any reason. Id. ¶ 26. In 2016, Defendant established the Influenza Vaccination Declination Review Board (the “Review Board”) to review exemption requests. Id. ¶ 49. The Review Board reviewed all requests without personally identifiable information. Id. ¶ 51. That same year, Defendant amended the IRP, mandating that all employees receive the flu vaccine and eliminating exemptions based on personal reasons. Id. ¶¶ 27–28. Employees seeking an exemption had to

submit a standardized form to be completed by their physician (the “Request Form”). Id. ¶ 51. The 2016 Request Form asked whether the patient had an anaphylactic or severe allergic reaction after a previous influenza vaccine, and provided a space to describe the reaction. Id. ¶ 52; 2016 Exemption Request Form, ECF No. 47-1 at 27. In 2016, over ninety percent of medical exemption requests were granted based on a stated “anaphylactic or severe allergic reaction after a previous influenza vaccine.” 56.1 Stmt. ¶ 55. In 2017, Defendant issued an amended IRP (the “2017 IRP”). October 2017 IRP, ECF No. 47-1 at 23–25. It provided that Employees denied an exemption had to be vaccinated, and that those who were denied an exemption but declined the vaccine would be subject to discipline, including discharge. Id. The 2017 IRP provided that previously exempted employees were only required to attest that the medical condition or religious belief upon which their exemption was granted had not changed. Id. at 25. The 2017 Request Form asked, in relevant part, whether the patient is allergic to eggs, has other allergies, had a previous reaction to the flu vaccine, and if so, the date, duration, and description. The form also required the doctor to indicate whether the

patient had any other medical contraindications, whether such reaction was anaphylactic or severe, and whether an intervention or other treatment was required. 2017 Exemption Request Form, ECF No. 47-1 at 32–33. After the implementation of the 2017 IRP, the Review Board denied exemption requests based solely on an egg allergy and offered the employee FluBlok—the first flu vaccine developed without egg proteins, gelatin, latex, formaldehyde, preservatives, or antibiotics—in lieu of the traditional, egg-based vaccine. 56.1 Stmt. ¶ 59–60. FluBlok does not have any of the same ingredients as traditional, egg-based versions of the vaccine. Id. ¶ 41. The Review Board referred employees with purported allergies to Amina Abdeldaim, M.D., Defendant’s Clinical

Director of Inpatient Allergy, to determine whether FluBlok would be a suitable alternative for the employee. Id. ¶¶ 60–61. Dr. Abdeldaim examined employees and, depending on the circumstances, conducted a FluBlok skin test. Id. ¶ 62. A positive skin test tends to suggest that a patient is allergic to some component within FluBlok. Id. ¶ 65. If an employee tested negative, Dr. Abdeldaim offered the FluBlok vaccine. Id. Plaintiff characterizes her disability as an allergy to the flu vaccine. Compl. ¶ 1. During childhood, she reacted adversely to the vaccine, but does not recall that incident. 56.1 Stmt. ¶ 74. Around 2001, while in nursing school, Plaintiff was vaccinated a second time, and suffered another adverse reaction. Id. ¶ 75. This incident occurred prior to the availability of FluBlok. Id. ¶ 103. Plaintiff began experiencing shortness of breath and chest palpitations about fifteen to twenty-five minutes after receiving the vaccine, with the symptoms lasting around ten to twenty minutes. Pl. 56.1 Counterstmt. ¶ 10, ECF No. 65; Pl. Dep. Tr. at 15:2–17:13, ECF No. 47-2. Plaintiff was driving when the symptoms began and she paused on the road as her symptoms continued. Pl. 56.1 Counterstmt. ¶ 11; Pl. Dep. Tr. at 18:5–12. Plaintiff proceeded to drive

home, a short distance away. Pl. 56.1 Counterstmt. ¶ 12. Her symptoms resolved without medical intervention. Id. ¶ 16; 56.1 Stmt. ¶ 75; Pl. Dep. Tr. at 17:17–21, 18:21–24. In 2010 or 2011, Plaintiff described her 2001 reaction to her primary care physician, Vinod Aggarwal, M.D. Pl. Dep. Tr. at 27:13–28:14. Dr. Aggarwal advised Plaintiff to not receive the flu vaccine again. Id. at 75:19–76:8. She did not undergo further medical testing or evaluation to determine whether she had an allergy to the flu vaccine or any of its components. 56.1 Stmt. ¶ 76; Pl. 56.1 Counterstmt. ¶ 23. Prior to 2016, Plaintiff made verbal exemption requests as required by Defendant’s policy at that time. In 2016, she submitted to Defendant her first written request for a medical

exemption. 56.1 Stmt. ¶ 80. Dr. Aggarwal signed the form, indicating that Plaintiff had an “anaphylactic or severe allergic reaction after a previous influenza vaccination,” but offered no details about the reaction. 2016 Exemption Request Form. Id. at 82. Defendant approved her request, and Plaintiff wore a surgical mask for the duration of the 2016 flu season. Pl. 56.1 Counterstmt. ¶¶ 38, 39. On November 1, 2017, Plaintiff emailed Defendant, asking whether she needed to submit an exemption request for the 2017 flu season, and stating that her condition remained the same. 56.1 Stmt.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Beard v. Banks
548 U.S. 521 (Supreme Court, 2006)
Costello v. City of Burlington
632 F.3d 41 (Second Circuit, 2011)
Shahriar v. Smith & Wollensky Restaurant Group, Inc.
659 F.3d 234 (Second Circuit, 2011)
Brown v. City of Syracuse
673 F.3d 141 (Second Circuit, 2012)
Donna Heilweil v. Mount Sinai Hospital
32 F.3d 718 (Second Circuit, 1994)
John A. Francis v. City of Meriden
129 F.3d 281 (Second Circuit, 1997)
Jessica Ryan v. Grae & Rybicki, P.C.
135 F.3d 867 (Second Circuit, 1998)
Elizabeth Gordon v. New York City Board of Education
232 F.3d 111 (Second Circuit, 2000)
Joseph v. Treglia v. Town of Manlius
313 F.3d 713 (Second Circuit, 2002)
Pepsico, Inc. v. The Coca-Cola Company
315 F.3d 101 (Second Circuit, 2002)
McMillan v. City of New York
711 F.3d 120 (Second Circuit, 2013)
McBride v. BIC Consumer Products Manufacturing Co.
583 F.3d 92 (Second Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Norman v. NYU Langone Health System, Counsel Stack Legal Research, https://law.counselstack.com/opinion/norman-v-nyu-langone-health-system-nysd-2020.